Open AccessImpacts of Human Papillomavirus Immunization Programs on Rates of Anogenital Warts in British Columbia, Canada, 2000 to 2017
Author(s) -
Christine D Lukac,
Robine Donken,
Michael Otterstatter,
Olga Mazo,
Stanley Wong,
Fawziah Marra,
Laurie Smith,
Monika Naus,
Deborah Money,
Mel Krajden,
Troy Grennan,
Mark Gilbert,
Jason Wong,
Gina Ogilvie
Publication year - 2020
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000001235
Subject(s) - medicine , poisson regression , relative risk , confidence interval , demography , cohort , men who have sex with men , genital warts , rate ratio , human papillomavirus , cohort study , gynecology , population , family medicine , cervical cancer , human immunodeficiency virus (hiv) , environmental health , cancer , syphilis , sociology
In 2008, British Columbia (BC) implemented a school-based quadrivalent human papillomavirus (HPV-4) immunization program for girls born in 1994 or later. In 2015, an expanded clinic-based program included men who report sex with men (MSM) born in 1989 or later. To evaluate the impacts of HPV-4 programs on anogenital warts (AGWs), diagnosis rates were measured among women who report sex with men (WSM), men who report sex with women (MSW), and MSM.